Primary Cutaneous CD30+/ALK- ALCL with Transition into sALCL: Favourable Response after Systemic Administration with Brentuximab Vedotin! Unique Presentation in a Bulgarian Patient!

BACKGROUND: Modern drugs could sometimes be a good solution even to problematic patients. The cutaneous and systemic forms of the CD30 positive anaplastic large T-cell lymphoma could often be described as a suitable target for therapy with Brentuximab vedotin. CASE REPORT: We present the first case...

Descripción completa

Detalles Bibliográficos
Autores principales: Popova, Tanya Naskova, Radinov, Atanass, Stavrov, Konstantin, Temelkova, Ivanka, Terziev, Ivan, Lozev, Ilia, Lukanova, Detelina, Mangarov, Hristo, Wollina, Uwe, Tchernev, Georgi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Republic of Macedonia 2018
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6062288/
https://www.ncbi.nlm.nih.gov/pubmed/30087736
http://dx.doi.org/10.3889/oamjms.2018.289

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6062288/
https://www.ncbi.nlm.nih.gov/pubmed/30087736
http://dx.doi.org/10.3889/oamjms.2018.289

Ejemplares similares